MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. financial statements, including revenue, expenses, profit, and loss

The total revenue of 4016 for the last quarter is 81.06 M SAR, and it's 19.85% lower compared to the previous quarter. The net income of Q3 24 is 3.87 M SAR.